Skip to main content
Livermore
Livermore
ZHEN

Vigil Neuroscience, Inc.

VIGLDelisted Aug 5, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001827087

Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in Vigil Neuroscience, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
50
−1 vs. Q4 2024
Shares held
25.0M
+2.41M (+10.7%) vs. Q4 2024
Total value
$44.5M
+$6.11M (+15.9%) vs. Q4 2024
New holders
8
13 more added
Sold out
9
21 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 50 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 47 institutionsQ2 2022: 35 institutionsQ3 2022: 33 institutionsQ4 2022: 37 institutionsQ1 2023: 41 institutionsQ2 2023: 47 institutionsQ3 2023: 45 institutionsQ4 2023: 46 institutionsQ1 2024: 54 institutionsQ2 2024: 58 institutionsQ3 2024: 52 institutionsQ4 2024: 51 institutionsQ1 2025: 50 institutionsQ2 2025: 78 institutionsQ3 2025: 2 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $44.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $125.1MQ2 2022: $44.6MQ3 2022: $222.7MQ4 2022: $312.3MQ1 2023: $245.4MQ2 2023: $242.1MQ3 2023: $137.7MQ4 2023: $84.4MQ1 2024: $90.5MQ2 2024: $104.5MQ3 2024: $94.2MQ4 2024: $38.4MQ1 2025: $44.5MQ2 2025: $265.8MQ3 2025: $4.55KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding VIGL and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20252$4.55K
Q2 202578$265.8M
Q1 202550$44.5M
Q4 202451$38.4M
Q3 202452$94.2M
Q2 202458$104.5M
Q1 202454$90.5M
Q4 202346$84.4M
Q3 202345$137.7M
Q2 202347$242.1M
Q1 202341$245.4M
Q4 202237$312.3M
Q3 202233$222.7M
Q2 202235$44.6M
Q1 202247$125.1M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q4 2024.

Institutions holding VIGL in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Atlas Venture Life Science Advisors, LLC5,836,874$10.4M1.99%00.0%Unchanged
BVF Inc4,013,633$7.14M0.29%+2,200,000+121.3%Added
Siren, L.L.C.1,967,064$3.50M0.20%−23,974−1.2%Reduced
683 Capital Management, LLC1,740,000$3.10M0.31%+340,000+24.3%Added
Standard Life Aberdeen plc1,724,520$3.07M0.01%+1,196,048+226.3%Added
Sphera Funds Management Ltd.1,604,429$2.86M0.70%+102,000+6.8%Added
Ensign Peak Advisors, Inc1,578,116$2.81M0.01%+875,000+124.4%Added
Vanguard Group Inc1,048,823$1.87M0.00%+73,350+7.5%Added
Blair William & Co1,033,577$1.84M0.01%+709,677+219.1%Added
Pivotal bioVenture Partners Investment Advisor LLC560,595$997.9K0.81%00.0%Unchanged
Marshall Wace, LLP476,934$848.9K0.00%+210,039+78.7%Added
Rock Springs Capital Management LP471,958$840.1K0.05%00.0%Unchanged
BlackRock, Inc.419,145$746.1K0.00%−1,557−0.4%Reduced
ArrowMark Colorado Holdings LLC289,460$515.2K0.01%00.0%Unchanged
Woodline Partners LP252,799$450.0K0.00%−235,957−48.3%Reduced
Ikarian Capital, LLC250,000$445.0K0.14%−250,000−50.0%Reduced
Geode Capital Management, LLC244,534$435.3K0.00%+16,010+7.0%Added
Renaissance Technologies LLC219,400$390.5K0.00%−147,900−40.3%Reduced
Susquehanna International Group, LLP212,640$378.5K0.00%−240.0%Reduced
Trustees of Columbia University in the City of New York192,973$343.5K0.05%00.0%Unchanged
Squarepoint Ops LLC110,951$197.5K0.00%−2,645−2.3%Reduced
Morgan Stanley100,165$178.3K0.00%+100,154+910,490.9%Added
LPL Financial LLC80,959$144.1K0.00%+80,959New
Bridgeway Capital Management, LLC79,864$142.2K0.00%−20,200−20.2%Reduced
Boothbay Fund Management, LLC73,375$130.6K0.00%−73,375−50.0%Reduced
State Street Corp69,139$123.1K0.00%00.0%Unchanged
Northern Trust Corp61,119$108.8K0.00%−3,618−5.6%Reduced
Goldman Sachs Group Inc55,566$98.9K0.00%−201,076−78.3%Reduced
Gsa Capital Partners LLP41,128$73.0K0.01%+41,128New
Acadian Asset Management LLC35,555$62.0K0.00%−2,350−6.2%Reduced
Qube Research & Technologies Ltd31,570$56.2K0.00%−76,912−70.9%Reduced
SG Americas Securities, LLC21,417$38.0K0.00%+21,417New
American Century Companies Inc20,258$36.1K0.00%+288+1.4%Added
Two Sigma Advisers, LP17,900$31.9K0.00%−51,200−74.1%Reduced
Jane Street Group, LLC16,587$29.5K0.00%−32,225−66.0%Reduced
Cubist Systematic Strategies, LLC15,161$27.0K0.00%−8,959−37.1%Reduced
Millennium Management LLC13,575$24.2K0.00%−330,239−96.1%Reduced
Change Path, LLC13,500$24.0K0.00%+13,500New
Barclays PLC12,688$22.6K0.00%−51,361−80.2%Reduced
Dimensional Fund Advisors LP10,704$19.1K0.00%+10,704New
Point72 Asia (Singapore) Pte. Ltd.3,805$6.77K0.00%−7,031−64.9%Reduced
Tower Research Capital LLC (TRC)3,044$5.42K0.00%−5,890−65.9%Reduced
Bank of America Corp1,106$1.97K0.00%+9+0.8%Added
Advisor Group Holdings, Inc.501$8910.00%+501New
JPMorgan Chase & Co382$6800.00%00.0%Unchanged
Coldstream Capital Management Inc187$3330.00%+187New
UBS Group AG166$2950.00%+165+16,500.0%Added
BNP Paribas Arbitrage, SA150$2670.00%−78−34.2%Reduced
Point72 (DIFC) Ltd7$120.00%00.0%Unchanged
SBI Securities Co., Ltd.5$90.00%+5New
Citadel Advisors LLC0$00.00%−1,507,192−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−250,000−100.0%Sold out
Two Sigma Investments, LP0$00.00%−136,920−100.0%Sold out
Verition Fund Management LLC0$00.00%−107,536−100.0%Sold out
Citigroup Inc0$00.00%−18,130−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−15,543−100.0%Sold out
Engineers Gate Manager LP0$00.00%−13,695−100.0%Sold out
R Squared Ltd0$00.00%−910−100.0%Sold out
Federated Hermes, Inc.0$00.00%−313−100.0%Sold out